• Giovanna Jeronimo, Karen T Nozoe, Daniel N Polesel, Gustavo A Moreira, Sergio Tufik, and Monica L Andersen.
• Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.
• Nutrition. 2016 Mar 1; 32 (3): 391-3.

AbstractDuchenne muscular dystrophy (DMD) is the second most common hereditary genetic disease in humans and has elevated mortality. DMD is an X-linked, life-limiting progressive muscle-wasting disease found predominantly in boys and young men. One of the main treatments for patients with DMD is corticosteroids. However, long-term use may cause major side effects such as obesity, a reduction in vitamin D, and osteoporosis. Sleep-disordered breathing is a common condition among patients with DMD, especially obstructive sleep apnea (OSA). In children, OSA is associated with obesity and a reduction of vitamin D concentration. In this article we aim to explore the interrelationship that exists between corticosteroids, obesity, OSA, and the risk of osteoporosis. Our main hypothesis is that factors such as nutrition and sleep are related to obesity and OSA, respectively. In addition, the chronic use of corticosteroids, obesity, and OSA are factors that can reduce serum levels of vitamin D, triggering osteoporosis. Thus, these factors play a key role in affecting the quality of life for patients with DMD and intervention based on these aspects may improve survival.Copyright © 2016 Elsevier Inc. All rights reserved.

30 keywords...

hide…